Radical concurrent chemoradiotherapy (CRT) for non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Stilwell, C. H. [1 ]
Shrimali, R. K. [1 ]
Sharma, R. N. [1 ]
Nicolson, M. C. [1 ]
Steven, E. [1 ]
Bissett, J. D. [1 ]
机构：
[1] Aberdeen Royal Infirm, Aberdeen, Scotland
来源：
LUNG CANCER | 2013年 / 79卷
关键词：
D O I：
10.1016/S0169-5002(13)70182-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
182
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [31] Concurrent chemoradiotherapy with Gemcitabine for locally advanced non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
    Athanasiou, E
    Cyrgias, G
    Boinis, K
    Samantas, E
    Christodoulidou, M
    Tamvaki, F
    Panoussaki, E
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [32] CONCURRENT CHEMORADIOTHERAPY (CONCRT) USING CISPLATIN-VINORELBINE IN LOCALLY ADVANCED (LA) NON-SMALL CELL LUNG CANCER (NSCLC)
    Charalambous, Haris
    Katodritis, Nicos
    Vomvas, Demetrios
    Maimaris, Michalis
    Decatris, Marios
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1154 - S1154
  • [33] Concurrent Chemoradiotherapy (ConCRT) using Cisplatin-Vinorelbine in Locally Advanced (LA) Non-Small Cell Lung Cancer (NSCLC)
    Charalambous, H.
    Constantinou, I.
    Vomvas, D.
    Katodritis, N.
    Orphanos, G.
    Kyriacou, F.
    Porfiridis, I.
    Decatris, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S854 - S854
  • [34] Impact of age on chemoradiation (CRT) for locally advanced non-small cell lung cancer (NSCLC)
    Dallas, J. L.
    Sullivan, J. E.
    Riggs, C. E.
    Hou, W.
    LaPlant, K. D.
    George, T. J.
    Louzon, P.
    Lynch, J. W.
    Close, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Survival impact of concurrent chemoradiotherapy (CRT) with weekly cisplatin doses in patients with unresectable stage III non-small cell lung cancer (NSCLC) in a clinical referral center in Chile
    Pinto, F.
    Salinas Simonetti, C. J.
    Maria Paz, S.
    Orlandi, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S944 - S945
  • [36] An audit of sequential chemoradiotherapy for non-small cell lung cancer (NSCLC) at the Leeds Cancer Centre (LCC)
    Sun, F.
    Littlejohns, A.
    Fakih, O.
    Clarke, K.
    Franks, K.
    Snee, M.
    Dickinson, P.
    Jain, P.
    LUNG CANCER, 2019, 127 : S77 - S78
  • [37] Induction chemoradiotherapy for c-N2 non-small cell lung cancer (NSCLC)
    Yokomise, H
    Okamoto, T
    Gotoh, M
    Masuya, D
    Nakashima, T
    Ishikawa, S
    Yamamoto, Y
    Huang, C
    LUNG CANCER, 2005, 49 : S176 - S176
  • [38] Histoculture drug response assay guided concurrent chemoradiotherapy for non-small cell lung cancer
    Yoshimasu, T
    Oura, S
    Hirai, I
    Kokawa, Y
    Hata, K
    Kawago, M
    Tamaki, T
    Ohta, F
    Nakamura, R
    Okamura, Y
    LUNG CANCER, 2005, 49 : S176 - S176
  • [39] Outcomes of Concurrent Chemoradiotherapy in Elderly Patients with Stage III Non-Small Cell Lung Cancer
    Lee, Seok Ho
    Lee, Seung Heon
    Heo, Ho-Jin
    Sung, Kihoon
    Lee, Kyu Chan
    Jung, Sung Hwan
    Park, Jeong Woong
    Cho, Eun Kyung
    Ahn, Hee Kyung
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S685 - S685
  • [40] Concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: community hospital experience
    Rouvinov, K.
    Dudnik, J.
    Charkovski, T.
    Ariad, S.
    Lavrenkov, K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 533 - 533
12345